• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Tasso & InnoVero to Supply Anti-Doping Test to 2024 Paris Olympics, Expanded Partnership

by Syed Hamza Sohail 07/10/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– InnoVero, a global leader in providing innovative, athlete-centric collection technologies to anti-doping organizations worldwide and Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the extension of their partnership that was first initiated in 2021.

– In addition to collaboratively developing new athlete-centric solutions, InnoVero will continue to serve as the exclusive worldwide distributor of Tasso blood collection solutions for the anti-doping marketplace.

Revolutionizing Anti-Doping: InnoVero and Tasso’s SAFESystem™ for Secure, Painless Blood Testing

As part of the InnoVero SAFESystem™ product suite, a secure, intuitive, and virtually painless system for anti-doping blood testing has been co-developed. This system leverages Tasso’s signature capillary blood collection technology, eliminating the need for traditional venipuncture or fingerstick collections. This innovative solution has been well-received by athletes, doping control officers, administrators, and laboratories, and is increasingly utilized in anti-doping programs worldwide. Professional and Olympic sports organizations, including those for the upcoming Paris 2024 Olympic Games, have quickly adopted this athlete-centric technology.

InnoVero delivers innovation and integrity to the global anti-doping community with solutions that secure global athlete trust. The SAFESystem™ sample collection solutions, featuring advanced security mechanisms, ensure that sample collection bottles are secure, athlete-friendly, and tamper-evident. These features provide seamless and efficient use for athletes, doping control officers, and laboratories, serving clients globally.

“Our partnership with Tasso is helping us deliver on our promise to drive innovation and integrity in anti-doping products. Tasso’s signature capillary blood collection technology has significantly improved the blood collection process providing an efficient, easy-to-implement, and athletic-centric solution” said Gabe Baida, Executive Director of InnoVero. “The response to our Tasso-based collection system from athletes and anti-doping organizations has been very positive. We are pleased to extend our partnership with Tasso and excited to continue developing innovative solutions together at the forefront of anti-doping technology.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

M&A: Qualtrics Completes $6.75B Acquisition of Press Ganey Forsta

Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE

Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE

PathAI Partners to Deploy First AI-Powered Biospecimen Solutions

Roche Acquires PathAI to Automate Cancer Diagnostics in $1B Deal

Vocal Biomarkers: Helping Clinicians Detect What Patients Hesitate to Share

Vocal Biomarkers: Helping Clinicians Detect What Patients Hesitate to Share

Aidoc Secures $150M to Accelerate Enterprise-Scale Clinical AI Across 2,000 Hospitals

OpenAI Launches ChatGPT for Clinicians: Free AI Documentation and Research Tool for Verified Physicians

OpenAI Launches ChatGPT for Clinicians: Free AI Documentation and Research Tool for Verified Physicians

IKS Health Acquires TruBridge for Rural EHR and RCM Solutions Expansion

IKS Health Acquires TruBridge for Rural EHR and RCM Solutions Expansion

UT Austin is Building the Nation's First 'AI-Native' Hospital, Backed by $750M

Why UT Austin is Building an ‘AI-Native’ Hospital from Scratch

The Medtech Pitch Deck Casino: Why Hype Still Wins, and How Scrutiny Could Improve Everyone’s Odds

The Casino Model: Why Medtech VCs Are Betting Billions on Unproven AI

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |